Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;45(3):150-9.
doi: 10.1053/j.seminhematol.2008.04.006.

Decision-making when data and inferences are not conclusive: risk-benefit and acceptable regret approach

Iztok Hozo  1 , Michael J Schell, Benjamin Djulbegovic
Affiliations

Decision-making when data and inferences are not conclusive: risk-benefit and acceptable regret approach

Iztok Hozo et al. Semin Hematol. 2008 Jul.

Abstract

The absolute truth in research is unobtainable, as no evidence or research hypothesis is ever 100% conclusive. Therefore, all data and inferences can in principle be considered as "inconclusive." Scientific inference and decision-making need to take into account errors, which are unavoidable in the research enterprise. The errors can occur at the level of conclusions that aim to discern the truthfulness of research hypothesis based on the accuracy of research evidence and hypothesis, and decisions, the goal of which is to enable optimal decision-making under present and specific circumstances. To optimize the chance of both correct conclusions and correct decisions, the synthesis of all major statistical approaches to clinical research is needed. The integration of these approaches (frequentist, Bayesian, and decision-analytic) can be accomplished through formal risk:benefit (R:B) analysis. This chapter illustrates the rational choice of a research hypothesis using R:B analysis based on decision-theoretic expected utility theory framework and the concept of "acceptable regret" to calculate the threshold probability of the "truth" above which the benefit of accepting a research hypothesis outweighs its risks.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Evidence-based medicine in times of crisis.
    Djulbegovic B, Guyatt G. Djulbegovic B, et al. J Clin Epidemiol. 2020 Oct;126:164-166. doi: 10.1016/j.jclinepi.2020.07.002. Epub 2020 Jul 10. J Clin Epidemiol. 2020. PMID: 32659364 Free PMC article. No abstract available.
  • Evidence and Decision-Making.
    Djulbegovic B, Hozo I. Djulbegovic B, et al. Cancer Treat Res. 2023;189:1-24. doi: 10.1007/978-3-031-37993-2_1. Cancer Treat Res. 2023. PMID: 37789157
  • Optimism bias leads to inconclusive results-an empirical study.
    Djulbegovic B, Kumar A, Magazin A, Schroen AT, Soares H, Hozo I, Clarke M, Sargent D, Schell MJ. Djulbegovic B, et al. J Clin Epidemiol. 2011 Jun;64(6):583-93. doi: 10.1016/j.jclinepi.2010.09.007. Epub 2010 Dec 16. J Clin Epidemiol. 2011. PMID: 21163620 Free PMC article. Review.
  • Association of germline genetic variants in RFC, IL15 and VDR genes with minimal residual disease in pediatric B-cell precursor ALL.
    Dawidowska M, Kosmalska M, Sędek Ł, Szczepankiewicz A, Twardoch M, Sonsala A, Szarzyńska-Zawadzka B, Derwich K, Lejman M, Pawelec K, Obitko-Płudowska A, Pawińska-Wąsikowska K, Kwiecińska K, Kołtan A, Dyla A, Grzeszczak W, Kowalczyk JR, Szczepański T, Ziętkiewicz E, Witt M. Dawidowska M, et al. Sci Rep. 2016 Jul 18;6:29427. doi: 10.1038/srep29427. Sci Rep. 2016. PMID: 27427275 Free PMC article.
  • Which Threshold Model?
    Djulbegovic B, Hozo I. Djulbegovic B, et al. Cancer Treat Res. 2023;189:93-99. doi: 10.1007/978-3-031-37993-2_8. Cancer Treat Res. 2023. PMID: 37789164
See all "Cited by" articles

LinkOut - more resources